Vertanical GmbH

Chronic Low Back Pain

Vertanical GmbH focuses on chronic non-specific low back pain in patients who require drug treatment after non-opioid analgesics have not provided adequate relief or were not suitable because of contraindications or intolerance.

  • Pain reduction
  • Persistent musculoskeletal pain
  • Non-opioid treatment limitations

The sponsor’s clinical interest is centered on therapeutic options for patients with ongoing back pain where standard analgesic approaches are insufficient.

Analgesic Therapy

The research activity is directed toward pain management in a setting where treatment response remains inadequate, with attention to therapeutic efficacy in reducing discomfort associated with long-standing spinal pain.

  • Therapeutic pain control
  • Non-opioid pain management
  • Symptom relief

This area reflects interest in options for patients needing alternatives within musculoskeletal medicine.

Musculoskeletal Disorders

Vertanical GmbH is active in a field involving spinal pain and broader musculoskeletal disorders, particularly conditions that affect daily function and require ongoing medical attention.

  • Spinal pain
  • Functional impairment
  • Long-term symptom burden

The clinical focus aligns with treatment needs in chronic pain conditions managed within orthopaedic and pain-related care settings.

Therapeutic Development in Pain Medicine

The sponsor’s research landscape includes the development of treatment approaches for pain medicine, with emphasis on patients whose prior non-opioid options were ineffective or unsuitable.

  • Alternative pain therapies
  • Refractory pain
  • Clinical pain relief

Its work is situated in the management of chronic pain syndromes requiring targeted pharmacological intervention.

Want to learn more about this study or check if you can participate? Contact us.

Matched clinical trials

  • Study on the Effects of VER-01, Ibuprofen, and Paracetamol for Patients with Chronic Non-Specific Low Back Pain

    Not recruiting

    2 1 1
    Investigated diseases:
    Czechia Germany Poland Spain